Skip to content

Clinical Study of the effect of Vidangadi Ghanavati in Prameha (Diabetes Mellitus Type II).

Open labelled, active controlled, randomized evaluation of the effect of Vidangadi Ghanavati in Prameha vis a vis Diabetes Mellitus (Type II).

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/04/005719
Enrollment
60
Registered
2015-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Known cases of Diabetes mellitus type II or newly diagnosed cases of Diabetes mellitus type II

Interventions

Intervention1: Vidangadi ghana vati: Vidangadi ghana vati contains Vidang(Embelia ribes Burm.f.), Shala (Shorea robusta Gaertn), Arjun (Terminalia arjuna(Roxb.) W. & A), Katphala (Myria esculeuta Buch

Sponsors

PDEAs College of ayurved and research centre nigdi pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Either a known diabetic on treatment or a newly diagnosed diabetic. 2.Patients presenting classical symptoms of Prameha. 3.Patient with fasting blood sugar up to 250 mg% and post prandial blood sugar up to 500 mg%. 4.Patient showing good, fair and moderate control in HbA1c test.

Exclusion criteria

Exclusion criteria: 1.Patients with fasting blood sugar above 250 mg% and post prandial blood sugar above 500mg%. 2.Insulin Dependent Diabetes Mellitus (IDDM) and those who are under insulin therapy. 3.Pregnant and lactating mothers. 4.Patients with acute complications like Hyperglycemic coma, Ketoacidosis, and infections like gangrene. 5.Patients with chronic complications like Nephropathy, Neuropathy and Retinopathy. 6.Patients suffering from other diseases such as Tuberculosis, Cardiac diseases, HIV.

Design outcomes

Primary

MeasureTime frame
Assesment of symptoms and effest on BSL Fasting and Post prandial, Urine sugar and glycosylated haemoglobin HbA1c Timepoint: 90 days (3 months)

Secondary

MeasureTime frame
Assessment of Lipid profile, Body weight and body mass index.Timepoint: 90 days (3 months)

Countries

India

Contacts

Public ContactDrKrutika Jadhav

PDEAs College of Ayurved and Research Centre

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 25, 2026